Structural Characterization and Anticancer Activity of a New Anthraquinone from Senna velutina (Fabaceae)

In this study, a novel compound was isolated, identified, and its chemical structure was determined from the extract of the roots of Senna velutina. In addition, we sought to evaluate the anticancer potential of this molecule against melanoma and leukemic cell lines and identify the pathways of cell death involved. To this end, a novel anthraquinone was isolated from the barks of the roots of S. velutina, analyzed by HPLC-DAD, and its molecular structure was determined by nuclear magnetic resonance (NMR). Subsequently, their cytotoxic activity was evaluated by the (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) method against non-cancerous, melanoma, and leukemic cells. The migration of melanoma cells was evaluated by the scratch assay. The apoptosis process, caspase-3 activation, analysis of mitochondrial membrane potential, and measurement of ROS were evaluated by flow cytometry technique. In addition, the pharmacological cell death inhibitors NEC-1, RIP-1, BAPTA, Z-VAD, and Z-DEVD were used to confirm the related cell death mechanisms. With the results, it was possible to elucidate the novel compound characterized as 2′-OH-Torosaol I. In normal cells, the compound showed no cytotoxicity in PBMC but reduced the cell viability of all melanoma and leukemic cell lines evaluated. 2′-OH-Torosaol I inhibited chemotaxis of B16F10-Nex2, SK-Mel-19, SK-Mel-28 and SK-Mel-103. The cytotoxicity of the compound was induced by apoptosis via the intrinsic pathway with reduced mitochondrial membrane potential, increased levels of reactive oxygen species, and activation of caspase-3. In addition, the inhibitors demonstrated the involvement of necroptosis and Ca2+ in the death process and confirmed caspase-dependent apoptosis death as one of the main programmed cell death pathways induced by 2′-OH-Torosaol I. Taken together, the data characterize the novel anthraquinone 2′-OH-Torosaol I, demonstrating its anticancer activity and potential application in cancer therapy.

[1]  Jiamei Le,et al.  The Effects and Mechanisms of Sennoside A on Inducing Cytotoxicity, Apoptosis, and Inhibiting Metastasis in Human Chondrosarcoma Cells , 2022, Evidence-based complementary and alternative medicine : eCAM.

[2]  Quan-Yu Du,et al.  Induction of Apoptosis by Metabolites of Rhei Radix et Rhizoma (Da Huang): A Review of the Potential Mechanism in Hepatocellular Carcinoma , 2022, Frontiers in Pharmacology.

[3]  I. Puzanov,et al.  Managing Metastatic Melanoma in 2022: A Clinical Review. , 2022, JCO oncology practice.

[4]  Saleh A. Ahmed,et al.  Journey of anthraquinones as anticancer agents – a systematic review of recent literature , 2021, RSC advances.

[5]  S. Selvaraj,et al.  Calcium Signaling Regulates Autophagy and Apoptosis , 2021, Cells.

[6]  V. Kanase,et al.  Laxative activity of Ethanolic extract of Capparis moonii W. fruit. , 2021, Research Journal of Pharmacy and Technology.

[7]  B. Curti,et al.  Recent Advances in the Treatment of Melanoma. , 2021, The New England journal of medicine.

[8]  Arifullah Mohammed,et al.  Medicinal Plants with Anti-Leukemic Effects: A Review , 2021, Molecules.

[9]  D. B. Silva,et al.  Application of the metabolomics approach to the discovery of active compounds from Brazilian trees against resistant human melanoma cells. , 2021, Phytochemical analysis : PCA.

[10]  P. Naik.  Cutaneous Malignant Melanoma: A Review of Early Diagnosis and Management , 2021, World journal of oncology.

[11]  J. Simal-Gándara,et al.  Status and Challenges of Plant-Anticancer Compounds in Cancer Treatment , 2021, Pharmaceuticals.

[12]  Defang Li,et al.  The Anti-tumor Effects of p-Coumaric Acid on Melanoma A375 and B16 Cells , 2020, Frontiers in Oncology.

[13]  A. Mohammadian,et al.  Hypericin Induces Apoptosis in AGS Cell Line with No Significant Effect on Normal Cells , 2020, Iranian journal of pharmaceutical research : IJPR.

[14]  T. Zhu,et al.  Dimeric Tetrahydroanthracene Regioisomers and Their Monomeric Precursor Produced by Streptomyces fumigatiscleroticus HDN10255. , 2020, Journal of natural products.

[15]  Bonglee Kim,et al.  Plant Extracts as Possible Agents for Sequela of Cancer Therapies and Cachexia , 2020, Antioxidants.

[16]  Jung Sun Kim,et al.  Genome-enabled discovery of anthraquinone biosynthesis in Senna tora , 2020, Nature Communications.

[17]  W. Tian,et al.  Novel anthraquinone compounds as anticancer agents and their potential mechanism. , 2020, Future medicinal chemistry.

[18]  M. Fares,et al.  Molecular principles of metastasis: a hallmark of cancer revisited , 2020, Signal Transduction and Targeted Therapy.

[19]  L. Bouchier-Hayes,et al.  Targeting apoptotic caspases in cancer. , 2020, Biochimica et biophysica acta. Molecular cell research.

[20]  B. Perillo,et al.  ROS in cancer therapy: the bright side of the moon , 2020, Experimental & Molecular Medicine.

[21]  N. Hempel,et al.  Mitochondrial Calcium Regulation of Redox Signaling in Cancer , 2020, Cells.

[22]  I. Jacobs,et al.  Peripheral immune-based biomarkers in cancer immunotherapy: can we realize their predictive potential? , 2019, Journal of Immunotherapy for Cancer.

[23]  M. Speir,et al.  Flipping the dogma – phosphatidylserine in non-apoptotic cell death , 2019, Cell Communication and Signaling.

[24]  S. Ryter,et al.  Necroptosis: a crucial pathogenic mediator of human disease. , 2019, JCI insight.

[25]  E. Paredes-Gamero,et al.  Ethanolic Extract of Senna velutina Roots: Chemical Composition, In Vitro and In Vivo Antitumor Effects, and B16F10-Nex2 Melanoma Cell Death Mechanisms , 2019, Oxidative medicine and cellular longevity.

[26]  M. Wink,et al.  In vitro wound healing of tumor cells: inhibition of cell migration by selected cytotoxic alkaloids , 2019, BMC Pharmacology and Toxicology.

[27]  M. Shibanuma,et al.  A mitochondrial ROS pathway controls matrix metalloproteinase 9 levels and invasive properties in RAS‐activated cancer cells , 2018, The FEBS journal.

[28]  Jian Ni,et al.  Emodin induces apoptosis in human hepatocellular carcinoma HepaRG cells via the mitochondrial caspase-dependent pathway , 2018, Oncology reports.

[29]  D. Baldivia,et al.  Evaluation of In Vitro Antioxidant and Anticancer Properties of the Aqueous Extract from the Stem Bark of Stryphnodendron adstringens , 2018, International journal of molecular sciences.

[30]  K. Nurgali,et al.  Editorial: Adverse Effects of Cancer Chemotherapy: Anything New to Improve Tolerance and Reduce Sequelae? , 2018, Front. Pharmacol..

[31]  Behzad Baradaran,et al.  The Different Mechanisms of Cancer Drug Resistance: A Brief Review , 2017, Advanced pharmaceutical bulletin.

[32]  R. Nussinov,et al.  Release of Cytochrome C from Bax Pores at the Mitochondrial Membrane , 2017, Scientific Reports.

[33]  O. Julien,et al.  Caspases and their substrates , 2017, Cell Death and Differentiation.

[34]  N. Chandel,et al.  The Two Faces of Reactive Oxygen Species in Cancer , 2017 .

[35]  Faisal T Thayyullathil,et al.  Reactive oxygen species and cancer paradox: To promote or to suppress? , 2017, Free radical biology & medicine.

[36]  D. Averill-Bates,et al.  Activation of apoptosis signalling pathways by reactive oxygen species. , 2016, Biochimica et biophysica acta.

[37]  L. Estevinho,et al.  The Chemical Profile of Senna velutina Leaves and Their Antioxidant and Cytotoxic Effects , 2016, Oxidative medicine and cellular longevity.

[38]  C. Müller,et al.  Anthraquinones As Pharmacological Tools and Drugs , 2016, Medicinal research reviews.

[39]  L. Dufossé,et al.  Anthraquinones and Derivatives from Marine-Derived Fungi: Structural Diversity and Selected Biological Activities , 2016, Marine drugs.

[40]  R. Birge,et al.  Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer , 2016, Cell Death and Differentiation.

[41]  Y. P. Subedi,et al.  A mode of action study of cationic anthraquinone analogs: a new class of highly potent anticancer agents , 2015 .

[42]  A. Kshirsagar,et al.  Anti-Inflammatory and Antiarthritic Activity of Anthraquinone Derivatives in Rodents , 2014, International journal of inflammation.

[43]  J. Guh,et al.  A unique amidoanthraquinone derivative displays antiproliferative activity against human hormone-refractory metastatic prostate cancers through activation of LKB1-AMPK-mTOR signaling pathway , 2014, Naunyn-Schmiedeberg's Archives of Pharmacology.

[44]  K. Schenke-Layland,et al.  Cell death stages in single apoptotic and necrotic cells monitored by Raman microspectroscopy , 2014, Scientific Reports.

[45]  A. Qureshi,et al.  Leukaemias: a review , 2013 .

[46]  Ajeet,et al.  Anticancer Potential of Plants and Natural Products: A Review , 2013 .

[47]  V. Bolzani,et al.  Natural products from Brazilian biodiversity as a source of new models for medicinal chemistry , 2012 .

[48]  K. Chan,et al.  Library synthesis and antibacterial investigation of cationic anthraquinone analogs. , 2012, ACS combinatorial science.

[49]  S. Babykutty,et al.  Aloe Emodin Induces G2/M Cell Cycle Arrest and Apoptosis via Activation of Caspase-6 in Human Colon Cancer Cells , 2012, Pharmacology.

[50]  Â. Pinto,et al.  Anthraquinones from the bark of Senna macranthera. , 2011, Anais da Academia Brasileira de Ciencias.

[51]  N. McLean,et al.  The management of malignant skin cancers , 2011 .

[52]  John S. Condeelis,et al.  Chemotaxis in cancer , 2011, Nature Reviews Cancer.

[53]  D. Green,et al.  Apoptosis and oncogenesis: give and take in the BCL-2 family. , 2011, Current opinion in genetics & development.

[54]  T. Hsia,et al.  Danthron, an anthraquinone derivative, induces DNA damage and caspase cascades-mediated apoptosis in SNU-1 human gastric cancer cells through mitochondrial permeability transition pores and Bax-triggered pathways. , 2011, Chemical research in toxicology.

[55]  Manuel T. Silva.  Secondary necrosis: The natural outcome of the complete apoptotic program , 2010, FEBS letters.

[56]  M. Hulett,et al.  Molecular mechanisms of late apoptotic/necrotic cell clearance , 2010, Cell Death and Differentiation.

[57]  M. Chung,et al.  Anti‐cancer properties of anthraquinones from rhubarb , 2007, Medicinal research reviews.

[58]  L. Galluzzi,et al.  Mechanisms of cytochrome c release from mitochondria , 2006, Cell Death and Differentiation.

[59]  J. Levine,et al.  Apoptotic Cells, at All Stages of the Death Process, Trigger Characteristic Signaling Events That Are Divergent from and Dominant over Those Triggered by Necrotic Cells , 2006, Journal of Biological Chemistry.

[60]  M. Gill,et al.  Austrocolorins A1 and B1: atropisomeric 10,10'-linked dihydroanthracenones from an Australian Dermocybe sp. , 2004, Phytochemistry.

[61]  Sten Orrenius,et al.  Calcium: Regulation of cell death: the calcium–apoptosis link , 2003, Nature Reviews Molecular Cell Biology.

[62]  D. Barnard,et al.  Anti-human cytomegalovirus activity and toxicity of sulfonated anthraquinones and anthraquinone derivatives. , 1995, Antiviral research.

[63]  S. Kitanaka,et al.  Two New Bitetrahydroanthracenes from Roots of Cassia occidentalis L. , 1989 .

[64]  Natural Products as Treatment against Cancer: A Historical and Current Vision , 2019 .

[65]  Christine Unger,et al.  In vitro cell migration and invasion assays. , 2013, Mutation research.

[66]  W. Gritsanapan,et al.  IN VITRO EVALUATION OF ANTIFUNGAL ACTIVITY OF ANTHRAQUINONE DERIVATIVES OF SENNA ALATA , 2010 .

[67]  M. Endo,et al.  Antimicrobial and antispasmodic tetrahydroanthracenes from Cassia singueana , 1980 .